- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Autoimmune Disorder Drug Delivery Device will have significant change from previous year. By the most conservative estimates of global Autoimmune Disorder Drug Delivery Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Autoimmune Disorder Drug Delivery Device market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disorder Drug Delivery Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Pen Injectors
Auto-Injectors
Prefilled Syringes
Vials
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
In-house Manufacturing
Outsourced Manufacturing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AbbVie Inc.
Amgen Inc.
F. Hoffmann- La Roche Ltd.
Novartis AG
GlaxoSmithKline Plc
Biogen Inc.
Merck KGaA
Bayer AG
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lily and Company
Sanofi S.A.
Takeda Pharmaceutical Company Limited
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autoimmune Disorder Drug Delivery Device Consumption 2016-2026
2.1.2 Autoimmune Disorder Drug Delivery Device Consumption CAGR by Region
2.2 Autoimmune Disorder Drug Delivery Device Segment by Type
2.2.1 Pen Injectors
2.2.2 Auto-Injectors
2.2.3 Prefilled Syringes
2.2.4 Vials
2.3 Autoimmune Disorder Drug Delivery Device Sales by Type
2.3.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2016-2021)
2.3.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Type (2016-2021)
2.3.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Type (2016-2021)
2.4 Autoimmune Disorder Drug Delivery Device Segment by Application
2.4.1 In-house Manufacturing
2.4.2 Outsourced Manufacturing
2.5 Autoimmune Disorder Drug Delivery Device Sales by Application
2.5.1 Global Autoimmune Disorder Drug Delivery Device Sale Market Share by Application (2016-2021)
2.5.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Application (2016-2021)
2.5.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Application (2016-2021)
3 Global Autoimmune Disorder Drug Delivery Device by Company
3.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Company
3.1.1 Global Autoimmune Disorder Drug Delivery Device Sales by Company (2019-2021)
3.1.2 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Company (2019-2021)
3.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company
3.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2019-2021)
3.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company (2019-2021)
3.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Company
3.4 Global Manufacturers Autoimmune Disorder Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autoimmune Disorder Drug Delivery Device Product Location Distribution
3.4.2 Players Autoimmune Disorder Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Autoimmune Disorder Drug Delivery Device by Region
4.1 Global Autoimmune Disorder Drug Delivery Device by Region
4.1.1 Global Autoimmune Disorder Drug Delivery Device Sales by Region
4.1.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Region
4.2 Americas Autoimmune Disorder Drug Delivery Device Sales Growth
4.3 APAC Autoimmune Disorder Drug Delivery Device Sales Growth
4.4 Europe Autoimmune Disorder Drug Delivery Device Sales Growth
4.5 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Growth
5 Americas
5.1 Americas Autoimmune Disorder Drug Delivery Device Sales by Country
5.1.1 Americas Autoimmune Disorder Drug Delivery Device Sales by Country (2016-2021)
5.1.2 Americas Autoimmune Disorder Drug Delivery Device Revenue by Country (2016-2021)
5.2 Americas Autoimmune Disorder Drug Delivery Device Sales by Type
5.3 Americas Autoimmune Disorder Drug Delivery Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disorder Drug Delivery Device Sales by Region
6.1.1 APAC Autoimmune Disorder Drug Delivery Device Sales by Region (2016-2021)
6.1.2 APAC Autoimmune Disorder Drug Delivery Device Revenue by Region (2016-2021)
6.2 APAC Autoimmune Disorder Drug Delivery Device Sales by Type
6.3 APAC Autoimmune Disorder Drug Delivery Device Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Autoimmune Disorder Drug Delivery Device by Country
7.1.1 Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2016-2021)
7.1.2 Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2016-2021)
7.2 Europe Autoimmune Disorder Drug Delivery Device Sales by Type
7.3 Europe Autoimmune Disorder Drug Delivery Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Autoimmune Disorder Drug Delivery Device by Country
8.1.1 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2016-2021)
8.1.2 Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2016-2021)
8.2 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Type
8.3 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Autoimmune Disorder Drug Delivery Device Distributors
10.3 Autoimmune Disorder Drug Delivery Device Customer
11 Global Autoimmune Disorder Drug Delivery Device Market Forecast
11.1 Global Autoimmune Disorder Drug Delivery Device Forecast by Region
11.1.1 Global Autoimmune Disorder Drug Delivery Device Forecast by Regions (2021-2026)
11.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Autoimmune Disorder Drug Delivery Device Forecast by Type
11.7 Global Autoimmune Disorder Drug Delivery Device Forecast by Application
12 Key Players Analysis
12.1 AbbVie Inc.
12.1.1 AbbVie Inc. Company Information
12.1.2 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offered
12.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AbbVie Inc. Main Business Overview
12.1.5 AbbVie Inc. Latest Developments
12.2 Amgen Inc.
12.2.1 Amgen Inc. Company Information
12.2.2 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
12.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Amgen Inc. Main Business Overview
12.2.5 Amgen Inc. Latest Developments
12.3 F. Hoffmann- La Roche Ltd.
12.3.1 F. Hoffmann- La Roche Ltd. Company Information
12.3.2 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
12.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 F. Hoffmann- La Roche Ltd. Main Business Overview
12.3.5 F. Hoffmann- La Roche Ltd. Latest Developments
12.4 Novartis AG
12.4.1 Novartis AG Company Information
12.4.2 Novartis AG Autoimmune Disorder Drug Delivery Device Product Offered
12.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Novartis AG Main Business Overview
12.4.5 Novartis AG Latest Developments
12.5 GlaxoSmithKline Plc
12.5.1 GlaxoSmithKline Plc Company Information
12.5.2 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offered
12.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 GlaxoSmithKline Plc Main Business Overview
12.5.5 GlaxoSmithKline Plc Latest Developments
12.6 Biogen Inc.
12.6.1 Biogen Inc. Company Information
12.6.2 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
12.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Biogen Inc. Main Business Overview
12.6.5 Biogen Inc. Latest Developments
12.7 Merck KGaA
12.7.1 Merck KGaA Company Information
12.7.2 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offered
12.7.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Merck KGaA Main Business Overview
12.7.5 Merck KGaA Latest Developments
12.8 Bayer AG
12.8.1 Bayer AG Company Information
12.8.2 Bayer AG Autoimmune Disorder Drug Delivery Device Product Offered
12.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Bayer AG Main Business Overview
12.8.5 Bayer AG Latest Developments
12.9 Johnson & Johnson Services Inc.
12.9.1 Johnson & Johnson Services Inc. Company Information
12.9.2 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offered
12.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Johnson & Johnson Services Inc. Main Business Overview
12.9.5 Johnson & Johnson Services Inc. Latest Developments
12.10 Teva Pharmaceutical Industries Ltd.
12.10.1 Teva Pharmaceutical Industries Ltd. Company Information
12.10.2 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
12.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
12.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12.11 Eli Lily and Company
12.11.1 Eli Lily and Company Company Information
12.11.2 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offered
12.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Eli Lily and Company Main Business Overview
12.11.5 Eli Lily and Company Latest Developments
12.12 Sanofi S.A.
12.12.1 Sanofi S.A. Company Information
12.12.2 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offered
12.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Sanofi S.A. Main Business Overview
12.12.5 Sanofi S.A. Latest Developments
12.13 Takeda Pharmaceutical Company Limited
12.13.1 Takeda Pharmaceutical Company Limited Company Information
12.13.2 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offered
12.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Takeda Pharmaceutical Company Limited Main Business Overview
12.13.5 Takeda Pharmaceutical Company Limited Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Autoimmune Disorder Drug Delivery Device Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Pen Injectors
Table 3. Major Players of Auto-Injectors
Table 4. Major Players of Prefilled Syringes
Table 5. Major Players of Vials
Table 6. Global Autoimmune Disorder Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 7. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 8. Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2016-2021) & ($ million)
Table 9. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2016-2021)
Table 10. Global Autoimmune Disorder Drug Delivery Device Sale Price by Type (2016-2021)
Table 11. Global Autoimmune Disorder Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 12. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 13. Global Autoimmune Disorder Drug Delivery Device Value by Application (2016-2021)
Table 14. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2016-2021)
Table 15. Global Autoimmune Disorder Drug Delivery Device Sale Price by Application (2016-2021)
Table 16. Global Autoimmune Disorder Drug Delivery Device Sales by Company (2019-2021) & (K Units)
Table 17. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Company (2019-2021)
Table 18. Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company (2019-2021)
Table 20. Global Autoimmune Disorder Drug Delivery Device Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Autoimmune Disorder Drug Delivery Device Producing Area Distribution and Sales Area
Table 22. Players Autoimmune Disorder Drug Delivery Device Products Offered
Table 23. Autoimmune Disorder Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Autoimmune Disorder Drug Delivery Device Sales by Region (2016-2021) (K Units)
Table 27. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2016-2021)
Table 28. Global Autoimmune Disorder Drug Delivery Device Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2016-2021)
Table 30. Americas Autoimmune Disorder Drug Delivery Device Sales by Country (2016-2021) & (K Units)
Table 31. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2016-2021)
Table 32. Americas Autoimmune Disorder Drug Delivery Device Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2016-2021)
Table 34. Americas Autoimmune Disorder Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 35. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 36. Americas Autoimmune Disorder Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 37. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 38. APAC Autoimmune Disorder Drug Delivery Device Sales by Region (2016-2021) & (K Units)
Table 39. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2016-2021)
Table 40. APAC Autoimmune Disorder Drug Delivery Device Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2016-2021)
Table 42. APAC Autoimmune Disorder Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 43. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 44. APAC Autoimmune Disorder Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 45. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 46. Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2016-2021) & (K Units)
Table 47. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2016-2021)
Table 48. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2016-2021)
Table 50. Europe Autoimmune Disorder Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 51. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 52. Europe Autoimmune Disorder Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 53. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Autoimmune Disorder Drug Delivery Device
Table 63. Key Application and Potential Industries of Autoimmune Disorder Drug Delivery Device
Table 64. Key Challenges of Autoimmune Disorder Drug Delivery Device
Table 65. Key Trends of Autoimmune Disorder Drug Delivery Device
Table 66. Autoimmune Disorder Drug Delivery Device Distributors List
Table 67. Autoimmune Disorder Drug Delivery Device Customer List
Table 68. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Autoimmune Disorder Drug Delivery Device Consumption Market Forecast by Region
Table 70. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Autoimmune Disorder Drug Delivery Device Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Autoimmune Disorder Drug Delivery Device Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Application (2021-2026)
Table 88. AbbVie Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 89. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 90. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. AbbVie Inc. Main Business
Table 92. AbbVie Inc. Latest Developments
Table 93. Amgen Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 95. Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Amgen Inc. Main Business
Table 97. Amgen Inc. Latest Developments
Table 98. F. Hoffmann- La Roche Ltd. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 99. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
Table 100. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. F. Hoffmann- La Roche Ltd. Main Business
Table 102. F. Hoffmann- La Roche Ltd. Latest Developments
Table 103. Novartis AG Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis AG Autoimmune Disorder Drug Delivery Device Product Offered
Table 105. Novartis AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. Novartis AG Main Business
Table 107. Novartis AG Latest Developments
Table 108. GlaxoSmithKline Plc Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offered
Table 110. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. GlaxoSmithKline Plc Main Business
Table 112. GlaxoSmithKline Plc Latest Developments
Table 113. Biogen Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 115. Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. Biogen Inc. Main Business
Table 117. Biogen Inc. Latest Developments
Table 118. Merck KGaA Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offered
Table 120. Merck KGaA Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. Merck KGaA Main Business
Table 122. Merck KGaA Latest Developments
Table 123. Bayer AG Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Bayer AG Autoimmune Disorder Drug Delivery Device Product Offered
Table 125. Bayer AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. Bayer AG Main Business
Table 127. Bayer AG Latest Developments
Table 128. Johnson & Johnson Services Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 129. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 130. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 131. Johnson & Johnson Services Inc. Main Business
Table 132. Johnson & Johnson Services Inc. Latest Developments
Table 133. Teva Pharmaceutical Industries Ltd. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 134. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
Table 135. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 136. Teva Pharmaceutical Industries Ltd. Main Business
Table 137. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 138. Eli Lily and Company Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 139. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offered
Table 140. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 141. Eli Lily and Company Main Business
Table 142. Eli Lily and Company Latest Developments
Table 143. Sanofi S.A. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offered
Table 145. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 146. Sanofi S.A. Main Business
Table 147. Sanofi S.A. Latest Developments
Table 148. Takeda Pharmaceutical Company Limited Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 149. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offered
Table 150. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 151. Takeda Pharmaceutical Company Limited Main Business
Table 152. Takeda Pharmaceutical Company Limited Latest Developments
List of Figures
Figure 1. Picture of Autoimmune Disorder Drug Delivery Device
Figure 2. Autoimmune Disorder Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autoimmune Disorder Drug Delivery Device Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Autoimmune Disorder Drug Delivery Device Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Autoimmune Disorder Drug Delivery Device Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Pen Injectors
Figure 10. Product Picture of Auto-Injectors
Figure 11. Product Picture of Prefilled Syringes
Figure 12. Product Picture of Vials
Figure 13. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type in 2020
Figure 14. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2016-2021)
Figure 15. Autoimmune Disorder Drug Delivery Device Consumed in In-house Manufacturing
Figure 16. Global Autoimmune Disorder Drug Delivery Device Market: In-house Manufacturing (2016-2021) & (K Units)
Figure 17. Autoimmune Disorder Drug Delivery Device Consumed in Outsourced Manufacturing
Figure 18. Global Autoimmune Disorder Drug Delivery Device Market: Outsourced Manufacturing (2016-2021) & (K Units)
Figure 19. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2016-2021)
Figure 20. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application in 2020
Figure 21. Autoimmune Disorder Drug Delivery Device Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company in 2020
Figure 23. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Regions (2016-2021)
Figure 24. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region in 2020
Figure 25. Americas Autoimmune Disorder Drug Delivery Device Sales 2016-2021 (K Units)
Figure 26. Americas Autoimmune Disorder Drug Delivery Device Revenue 2016-2021 ($ Millions)
Figure 27. APAC Autoimmune Disorder Drug Delivery Device Sales 2016-2021 (K Units)
Figure 28. APAC Autoimmune Disorder Drug Delivery Device Revenue 2016-2021 ($ Millions)
Figure 29. Europe Autoimmune Disorder Drug Delivery Device Sales 2016-2021 (K Units)
Figure 30. Europe Autoimmune Disorder Drug Delivery Device Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue 2016-2021 ($ Millions)
Figure 33. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2020
Figure 34. Americas Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2020
Figure 35. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Type in 2020
Figure 36. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Application in 2020
Figure 37. United States Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Region in 2020
Figure 42. APAC Autoimmune Disorder Drug Delivery Device Revenue Market Share by Regions in 2020
Figure 43. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Type in 2020
Figure 44. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Application in 2020
Figure 45. China Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2020
Figure 52. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2020
Figure 53. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Type in 2020
Figure 54. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Application in 2020
Figure 55. Germany Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Application in 2020
Figure 64. Egypt Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Autoimmune Disorder Drug Delivery Device Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
